1,916 results on '"Morishita, Ryuichi"'
Search Results
52. PS-R04-8: DIFFERENTIAL RECOVERY OF IMPAIRED ENDOTHELIAL AND RENAL FUNCTION IN A CASE OF MALIGNANT HYPERTENSION
53. PS-B10-12: A NOVEL PLATFORM FOR A LARGE-VOLUME CSF COLLECTION IN THE FREE-BEHAVING MICE AS A PRECLINICAL MODEL FOR BIOMARKER DEVELOPMENT.
54. PS-B05-10: DIABETES MELLITUS AGGRAVATES BEHAVIORAL DEFICIT AND INCREASES SITE-SPECIFIC PHOSPHORYLATION OF TAU PROTEIN IN ALZHEIMER'S DISEASE MOUSE MODEL
55. PS-BPB07-1: DEVELOPMENT OF ANTI-THROMBOTIC VACCINE AGAINST HUMAN S100A9
56. Antioxidation in Prevention of Cardiovascular Diseases – An Effect of Polyphenols
57. OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice
58. Therapeutic vaccine against DPP4 improves glucose metabolism in mice
59. Diabetes and Alzheimer’s Disease
60. Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke
61. Therapeutic Vaccines for Hypertension: a New Option for Clinical Practice
62. Influence of periostin-positive cell-specific Klf5 deletion on aortic thickening in DOCA-salt hypertensive mice
63. Current therapies and investigational drugs for peripheral arterial disease
64. Gene Therapy vs Pharmacotherapy
65. Blocking Periostin Prevented Development of Inflammation in Rhabdomyolysis-Induced Acute Kidney Injury Mice Model
66. Increased blood–brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model
67. Inhibition of Aneurysm Progression by Direct Renin Inhibition in a Rabbit Model
68. Abstract 14985: Development of a Proprotein Convertase Subtilisin/Kexin Type 9 Epitope Vaccine for Dyslipidemia in Mice
69. Association between renin–angiotensin–aldosterone system blockade and future osteoporotic fracture risk in hypertensive population: A population-based cohort study in Taiwan
70. Angiotensin II Peptide Vaccine Protects Ischemic Brain Through Reducing Oxidative Stress
71. Gene Therapy for Myocardial Infarction: A Real Medicine in the Next Millenium?
72. Continuous infusion of angiotensin II modulates hypertrophic differentiation and apoptosis of chondrocytes in cartilage formation in a fracture model mouse
73. Hepatocyte growth factor stimulated angiogenesis without inflammation: Differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor
74. Role of serotonin in angiogenesis: Induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice
75. Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults
76. Functional Analysis of Tissue Renin-Angiotensin System Using 'Gain and Loss of Function' Approaches: In Vivo Test of in Vitro Hypothesis
77. Gene Therapy for Myocardial Infarction
78. Transfection of Heat-Shock Protein 70 Enhances Myocardial Tolerance to Ischemia: Evidence for a Role of HSP70 in Ischemia-Reperfusion Injury
79. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes
80. DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HJV)-liposomes
81. Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease
82. Development of Protein-Liposome Gene Delivery System and Its Application for the Treatment of Acquired Diseases
83. Systemic Administration of Ribbon-type Decoy Oligodeoxynucleotide Against Nuclear Factor κB and Ets Prevents Abdominal Aortic Aneurysm in Rat Model
84. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly( d, l-lactide-co-glycolide) nanospheres for inflammatory bowel disease
85. Lipoprotein (a) is an Upstream Mediator of Aortic Stenosis
86. Additional file 1 of A novel chronic dural port platform for continuous collection of cerebrospinal fluid and intrathecal drug delivery in free-moving mice
87. Evaluating the potential of the GFAP‐KLH immune‐tolerizing vaccine for type 1 diabetes in mice
88. Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance
89. Estrogen attenuates vascular remodeling in Lp(a) transgenic mice
90. Selective Blockade of Periostin Exon 17 Preserves Cardiac Performance in Acute Myocardial Infarction
91. Are diuretic additives fit for uncontrolled hypertensive patients receiving telmisartan and amlodipine treatment?
92. Effect of angiotensin II receptor blocker, olmesartan, on turnover of bone metabolism in bedridden elderly hypertensive women with disuse syndrome
93. Vascular protective effects of ezetimibe in ApoE-deficient mice
94. Nonviral Retrograde Gene Transfer of Human Hepatocyte Growth Factor Improves Neuropathic Pain-related Phenomena in Rats
95. Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration
96. Validation of Aβ1–40 administration into mouse cerebroventricles as an animal model for Alzheimer disease
97. Gene Therapy Inhibiting Neointimal Vascular Lesion: In vivo Transfer of Endothelial Cell Nitric Oxide Synthase Gene
98. A Gene Therapy Strategy Using a Transcription Factor Decoy of the E2F Binding Site Inhibits Smooth Muscle Proliferation in vivo
99. The Angiotensin II Type 2 (AT 2 ) Receptor Antagonizes the Growth Effects of the AT 1 Receptor: Gain-of-Function Study Using Gene Transfer
100. Single Intraluminal Delivery of Antisense cdc2 Kinase and Proliferating- Cell Nuclear Antigen Oligonucleotides Results in Chronic Inhibition of Neointimal Hyperplasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.